pricing
India ‘likely’ to increase price caps
June 25, 2014Manufacturing and Production, Sales and Marketing China, FDA, India, UK, pricing
India’s government is ‘likely’ to increase the number of drugs which are subject to price caps, according to a report …
Drug prices defy gravity – until patent expiry
June 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina, LaMattina, Pfizer, drug, pharma, pricing, research
How drugs are priced is a hot topic these days, and a new Bloomberg article will cause it to heat-up …
Ireland agrees deal on medicines
June 28, 2012Business Services, Sales and Marketing AstraZeneca, IPHA, Ireland, Lundbeck, Novartis, pricing
Ireland’s pharmaceutical industry has agreed a deal with the country’s government which breaks a deadlock over prices and access. The …
Witty warns EU leaders over pricing
June 27, 2012Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing
Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …
UK drug pricing: ABPI wants evolution, not revolution
June 14, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing
As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …
New drug discounts should be made transparent
February 8, 2012Medical Communications, Sales and Marketing ABPI, NHS, NICE, access scheme, pricing
Patient access schemes agreed through NICE should be made more transparent. This is according to Paul McManus, a pharmacist and …
Daiichi Sankyo: Europe poses huge challenge for pharma
June 9, 2011Research and Development, Sales and Marketing Cancer, Daiichi Sankyo, pricing
Japanese pharma company Daiichi Sankyo is expanding its European operations, creating a new oncology business unit. But outlining its plans …
Price transparency and timing at risk, warns EFPIA
June 9, 2011Sales and Marketing Drug pricing, EFPIA, medicines pricing, pricing
Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …
Value-based pricing for UK pharma by 2014
July 13, 2010Sales and Marketing government, pricing
The UK government plans to radically overhaul the way medicines are paid for, introducing a value-based pricing system within the …
Italy plans cancer drug price cut
July 7, 2010Sales and Marketing Italy, economic climate, global pricing, price cuts, pricing
Italy will cut drug prices next year as it adopts a ‘pay for performance’ approach to drug pricing. This will …
Europe must move on from ‘simplistic’ pricing
June 22, 2010Research and Development Europe, hta, pricing, pricing & Reimbursement
GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …
Let’s avoid further stand-offs, says Witty
June 22, 2010Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing
Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …
Novo agrees price cut deal with Greece
June 16, 2010Sales and Marketing Greece, Novo Nordisk, insulin, pricing
Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …
Implementing value-based pricing in the UK
June 14, 2010Sales and Marketing hta, pricing, value
The UK has a strong history of innovation in medicines and it is vital to the economy that this continues …
Novo withdraws insulins in Greece price protest
May 31, 2010Sales and Marketing Greece, pricing
Insulin manufacturer Novo Nordisk says it will withdraw its modern insulin products from Greece in protest at a 25% price …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
